|Unit Price:||USD 1.0000 / Kilogram |
|Min. Order:||1 Kilogram|
|Delivery Time:||15 Days|
Model No.: 1611493-60-7
Packaging: As required
Place of Origin: CHINA
Certificate: Technical Support
Bictegravir CAS number is 1611493-60-7, developed code is GS-9883, is a new class of integrase inhibitors. Unlike the previously developed integrase inhibitors, Bictegravir only needs to be used once a day without the synergist cobicistat. In the third phase of clinical trials, the TAF/FTC/BIC protocol was studied. Previous studies have shown that Bictegravir CAS number 1611493-60-7 is well tolerated in healthy people, inhibits renal tubular transporter, reduces creatinine levels, and causes a decrease in glomerular filtration rate, but does not impair renal function. In addition, Bictegravir has a higher resistance barrier than other integrase inhibitors and has less interaction with other drugs.
A two-stage clinical placebo double-blind controlled trial was presented at the 2017 CROI conference in Boston to compare the efficacy of Bictegravir and dolutegravir as first-line treatments. The results of the study indicate that the Bictegravir regimen is similar in efficacy to the dolutegravir regimen and has good safety and tolerability. Bictegravir is recommended as the first choice for first-line treatment in treatment guidelines. in Europe and the United States. Bictegravir is another heavy medicine that will be put on the market in the field of HIV medicine since TAF.
Thera. Category:Integrase Inhibitor
Synonyms:Bictegravir;GS-9883; Bictegravir (GS-9883)
Packing:Export worthy packing
Material Safety Data Sheet:Available on request